Oligomeric compounds for the modulation of BLC-2

Details for Australian Patent Application No. 2004303464 (hide)

Owner Santaris Pharma A/S

Inventors Westergaard, Majken; Frieden, Miriam; Orum, Henrik; Thrue, Charlotte Albaeck; Hansen, Jens Bo

Agent FB Rice

Pub. Number AU-B-2004303464

PCT Pub. Number WO2005/061710

Priority 60/532,844 23.12.03 US; 60/586,340 07.07.04 US; PA 2003 01929 23.12.03 DK; 60/558,392 31.03.04 US; PA 2004 00517 31.03.04 DK; 60/621,594 22.10.04 US; PA 2004 01069 07.07.04 DK; PA 2004 01629 22.10.04 DK

Filing date 23 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 1 October 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061710 Priority application(s): WO2005/061710

1 October 2009 Application Accepted

  Published as AU-B-2004303464

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303466-Method for the direct and continuous production of hollow bodies from a polyester melt

2004303461-2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI